ATARA Biotherapeutics (ATRA) Misses Q1 EPS by 29c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of ($0.29). Revenue for the quarter came in at $520 thousand.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Rocket Lab launches U.S. Space Force mission in record 16 hours